Other
Baseline assessments
Baseline assessments is an intervention with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
33%
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Active, not recruiting1
Completed1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (50.0%)
N/A1 (50.0%)
Trials by Status
active_not_recruiting133%
completed133%
recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
recruitingphase_3
Metformin Treatment on Cognitive Impairment of Schizophrenia
NCT05838573
active_not_recruiting
Comparison of Strength, Weight Bearing, Proprioception, Reaction Time and Function in Scapholunate Instability
NCT07134452
completednot_applicable
VINCI-AD: An Investigation of Transcutaneous Vagus Nerve Stimulation in Mild Cognitive Impairment.
NCT05514756
Clinical Trials (3)
Showing 3 of 3 trials
NCT05838573Phase 3
Metformin Treatment on Cognitive Impairment of Schizophrenia
NCT07134452
Comparison of Strength, Weight Bearing, Proprioception, Reaction Time and Function in Scapholunate Instability
NCT05514756Not Applicable
VINCI-AD: An Investigation of Transcutaneous Vagus Nerve Stimulation in Mild Cognitive Impairment.
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3